Literature DB >> 2752281

The contribution of training to sensitivity in the nociceptive paw-withdrawal test.

Y O Taiwo1, T J Coderre, J D Levine.   

Abstract

An important limitation in behavioral tests of the hyperalgesic and analgesic effects of drugs is the low sensitivity of the measuring technique associated with inter- and intra-subject variability. Since familiarity with the experimental situation and novelty of the stimulus significantly influences an animal's behavior, we have tested the hypothesis that intensive training of rats, in the Randall-Selitto paw-withdrawal test, will increase the sensitivity of this test for detecting hyperalgesic effects of intradermal injections of the inflammatory mediator, bradykinin (BK). Mean baseline of the mechanical nociceptive threshold decreased between the first and second, and stabilized by the third day of training. Although there was no significant difference between the effects of BK or its vehicle (saline) on nociceptive threshold on day 1, on subsequent days BK produced a dose-dependent decrease in nociceptive threshold that could be distinguished from the effect of vehicle. These data demonstrate that training in the experimental paradigm can increase sensitivity for detecting hyperalgesic effects of inflammatory mediators in behavioral tests.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2752281     DOI: 10.1016/0006-8993(89)90950-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  44 in total

1.  Dissociation of tolerance and dependence for opioid peripheral antinociception in rats.

Authors:  K O Aley; J D Levine
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

2.  Alcohol consumption enhances antiretroviral painful peripheral neuropathy by mitochondrial mechanisms.

Authors:  Luiz F Ferrari; Jon D Levine
Journal:  Eur J Neurosci       Date:  2010-08-19       Impact factor: 3.386

3.  Regulation of Expression of Hyperalgesic Priming by Estrogen Receptor α in the Rat.

Authors:  Luiz F Ferrari; Dionéia Araldi; Jon D Levine
Journal:  J Pain       Date:  2017-01-09       Impact factor: 5.820

4.  Distinct terminal and cell body mechanisms in the nociceptor mediate hyperalgesic priming.

Authors:  Luiz F Ferrari; Dioneia Araldi; Jon D Levine
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

5.  Severity of alcohol-induced painful peripheral neuropathy in female rats: role of estrogen and protein kinase (A and Cepsilon).

Authors:  O A Dina; R W Gear; R O Messing; J D Levine
Journal:  Neuroscience       Date:  2007-01-03       Impact factor: 3.590

6.  Stress induces a switch of intracellular signaling in sensory neurons in a model of generalized pain.

Authors:  Sachia G Khasar; Jennifer Burkham; Olayinka A Dina; Adrienne S Brown; Oliver Bogen; Nicole Alessandri-Haber; Paul G Green; David B Reichling; Jon D Levine
Journal:  J Neurosci       Date:  2008-05-28       Impact factor: 6.167

7.  Second messengers mediating the expression of neuroplasticity in a model of chronic pain in the rat.

Authors:  Luiz F Ferrari; Oliver Bogen; Jon D Levine
Journal:  J Pain       Date:  2014-01-07       Impact factor: 5.820

8.  CD44 Signaling Mediates High Molecular Weight Hyaluronan-Induced Antihyperalgesia.

Authors:  Luiz F Ferrari; Eugen V Khomula; Dioneia Araldi; Jon D Levine
Journal:  J Neurosci       Date:  2017-11-24       Impact factor: 6.167

9.  Learned avoidance from noxious mechanical simulation but not threshold semmes weinstein filament stimulation after nerve injury in rats.

Authors:  Hsiang-En Wu; Geza Gemes; Vasiliki Zoga; Takashi Kawano; Quinn H Hogan
Journal:  J Pain       Date:  2009-11-27       Impact factor: 5.820

10.  Neurotoxic catecholamine metabolite in nociceptors contributes to painful peripheral neuropathy.

Authors:  Olayinka A Dina; Sachia G Khasar; Nicole Alessandri-Haber; Oliver Bogen; Xiaojie Chen; Paul G Green; David B Reichling; Robert O Messing; Jon D Levine
Journal:  Eur J Neurosci       Date:  2008-09-09       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.